Document Detail


Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab.
MedLine Citation:
PMID:  19479865     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Aseptic pachymeningitis is a rare and serious complication of rheumatoid arthritis (RA). Herein, we describe a patient with rheumatoid factor-positive and anti-cyclic citrullinated peptide-positive RA who experienced a focal seizure, with aphasia and convulsions of the right side of the body. The findings of magnetic resonance imaging and histologic analysis led to a diagnosis of rheumatoid pachymeningitis. Because the patient had a large number of CD20-expressing B lymphocytes, therapy with rituximab was started and has resulted in complete and sustained remission of both the pachymeningitis and the RA for >2 years. Despite a decrease in immunoglobulins, the patient has remained free of infections, which illustrates the favorable outcome that can result from therapeutic B cell depletion in this potentially lethal manifestation of RA.
Authors:
L Schmid; M Müller; T Treumann; W Arnold; B Möller; D Aeberli; P M Villiger
Related Documents :
15024135 - Development, validation and use of a patient knowledge questionnaire (pkq) for patients...
1319485 - Demonstration of cytomegalovirus (cmv) dna and anti-cmv response in the synovial membra...
1941815 - Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnove...
9470915 - Nail abnormalities in rheumatoid arthritis.
11697845 - Male gonadal dysfunction in patients with hodgkin's disease prior to treatment.
20522815 - Spontaneous angiographic conversion of intracranial dural arteriovenous shunt: long-ter...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Arthritis and rheumatism     Volume:  60     ISSN:  0004-3591     ISO Abbreviation:  Arthritis Rheum.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-16     Completed Date:  2009-08-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370605     Medline TA:  Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1632-4     Citation Subset:  AIM; IM    
Affiliation:
Kantonsspital, Lucerne, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / therapeutic use*
Antigens, CD20 / metabolism
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / complications*,  drug therapy*
B-Lymphocytes / immunology
Humans
Magnetic Resonance Imaging
Male
Meningitis / diagnosis,  drug therapy*,  etiology*
Middle Aged
Remission Induction
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antigens, CD20; 0/Antirheumatic Agents; 0/rituximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial...
Next Document:  Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of col...